Johnson & Johnson (NYSE:JNJ) recently announced promising Phase 3 results for icotrokinra, a new investigational treatment ...

An investigative history of the scandal-plagued company shines a light on a health care industry riddled with corruption and ...

Cramer noted that investors are skirting Johnson & Johnson (NYSE:JNJ) because of worries regarding Robert Kennedy Jr., as he ...

After failing to resolve tens of thousands of talc lawsuits with three unsuccessful bankruptcy attempts, Johnson & Johnson is ...

Gardiner Harris’s investigation of Johnson & Johnson explores the many ways corporate greed and weak regulations fail to protect the public.

In an April 16 motion, Johnson & Johnson cited 'serious ethical lapses' that justified removing Beasley Allen from the talc ...

Following a third failed bankruptcy maneuver by Johnson & Johnson , trial lawyers with Dallas-based Nachawati Law Group have filed three new lawsuits on behalf of women who developed cancer after ...

Federal agent Yasin Binda's testimony reveals items found inside Diddy's hotel room during his arrest last year. (Image via Cindy Ord/) Federal agent Yasin Binda testified against Sean "Diddy" Combs ...

Walgreens to pay $300 million to resolve allegations it unlawfully dispensed and billed for millions of opioid and controlled substance prescriptions, with an additional $50 million penalty if ...

Johnson & Johnson cited an order last month that Moline reveal the names of the 33 individuals in her 2020 report, which linked mesothelioma to cosmetic talcum powder. Last year, a federal judge ...

JNJ) $10 billion proposal to end tens of thousands of lawsuits alleging that its baby powder and other talc products cause ovarian cancer. Overall, JNJ ranks 5th on our list of top stocks to watch ...